You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: 2021 DORIS definition of remission in SLE: final recommendations from an international task force

https://doi.org/10.1136/lupus-2021-000538corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    van Vollenhoven RF, Bertsias G, Doria A, et al. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 2021;8:e000538. doi: 10.1136/lupus-2021-000538

    The authors want to alert the readers that a typographical error noticed in Box 1, has now been corrected. The final bullet point, referring to medications, was corrected from (prednisolone <5 mg/day) to (prednisolone <5 mg/day), as shown below.

    Box 1

    The 2021 DORIS definition of remission in SLE

    • Clinical SLEDAI=0.

    • Physician Global Assessment <0.5 (0–3).

      • Irrespective of serology.

      • The patient may be on antimalarials, low-dose glucocorticoids (prednisolone ≤5 mg/day), and/or stable immunosuppressives including biologics.